The document discusses the cost advantages of adequate acute pain management using non-opioid options such as intravenous paracetamol compared to opioid-related adverse events from opioids or gastrointestinal adverse events from NSAIDs. It provides several studies that have shown intravenous paracetamol to be effective for acute pain management after various surgeries and procedures while reducing costs associated with adverse events from alternative pain medications.